tirzepatide in children Efficacy and safety of and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial FDA reconsidering its decision to

Reduced appetite that crosses the line from helpful into uncomfortable

If you are interested in alternative dosing approaches like microdosing tirzepatide , discuss this with your prescriber so they can adjust the protocol appropriately and monitor your response under medical supervision

Researched throughly then ordered 12/18

Using the medication for 3 weeks now and happy with the results

The clinical trial numbers reflect this progression clearly

The lack of studies means dosing protocols are speculative, side effect profiles unknown, and risks potentially severe - particularly gastroparesis from combined extreme gastric slowing